Unlike cervical squamous cell carcinoma (CSCC), no uniform standard has been
implemented to identify serum biomarkers for adenocarcinoma of the cervix (ADC). In the …

Background: Cervical cancer (CC) is one of the most common cancers in women. This study
aimed to research the clinical and non-clinical features that may affect the prognosis of …

To develop and validate a nomograph to predict the long-term survival probability of cervical
cancer (CC) patients in Asia, Surveillance, Epidemiology, and End Results (SEER) were …

Background Cervical adenocarcinoma (CA) is the second most prevalent histological
subtype of cervical cancer, following cervical squamous cell carcinoma (CSCC). As stated in …

Background: To investigate the prognostic role of pretreatment squamous cell carcinoma
antigen (SCCA) in early-stage cervical cancer (CC). Methods: We enrolled 487 cases of …

Objectives Accurate prediction of prognosis will help adjust or optimize the treatment of
cervical cancer and benefit the patients. We aimed to investigate the incremental value of …

Objective To develop a risk stratification model based on the International Federation of
Gynecology and Obstetrics (FIGO) staging combined with squamous cell carcinoma antigen …

This study aimed to develop and validate a nomogram for predicting the overall survival of
cervical adenocarcinoma (CAC) patients using a large database comprising patients with …

Background Cervical cancer has long been a common malignance troubling women.
However, there are few studies developing nomogram with comprehensive factors for the …

Objective There is a lack of research evaluating the effect of tumor markers for prognosis in
cervical adenocarcinoma. We aimed to develop and validate a preoperative tumor-marker …